H Lundbeck A/S banner

H Lundbeck A/S
OTC:HLUBF

Watchlist Manager
H Lundbeck A/S Logo
H Lundbeck A/S
OTC:HLUBF
Watchlist
Price: 5.83 USD Market Closed
Market Cap: $5.8B

Profitability Summary

H Lundbeck A/S's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
H Lundbeck A/S

Margins Comparison
H Lundbeck A/S Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DK
H Lundbeck A/S
CSE:HLUN A
34.9B DKK
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
987B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
298.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.8B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
248.3B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
309B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.4B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.1B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
H Lundbeck A/S Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DK
H Lundbeck A/S
CSE:HLUN A
34.9B DKK
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
987B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
298.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.8B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
248.3B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
309B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.4B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
H Lundbeck A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate